Daptomycin-Resistant, Methicillin-ResistantStaphylococcus aureusBacteremia.
Mangili, A.; Bica, I.; Snydman, D. R.; Hamer, D. H.
[Report] Clinical Infectious Diseases. 40(7):1058-1060, April 1, 2005.

(Format: HTML, PDF)

: We describe a patient who developed daptomycin-resistant, methicillin-resistant Staphylococcus aureus (MRSA) during an episode of presumed septic thrombophlebitis of the portal vein. Although daptomycin is an alternative agent for treatment of drug-resistant gram-positive bacterial infections, development of resistance during prolonged use may occur with MRSA bacteremia from a persistent focus.

(C) Copyright Oxford University Press 2005.